Effect of centralized volume-based procurement of drugs on business performance of listed pharmaceutical enterprises

Since March 2018, China has conducted five rounds of negotiations for the inclusion of drugs in the medical insurance system and implemented eight batches of centralized drug procurement. The role of the medical insurance department as a strategic purchaser in the pharmaceutical market has been cont...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Zongjun Ke, Yue Zhang, Dingqiang Duan
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Subjects:	Volume-based procurement of drugs Listed pharmaceutical enterprises Business performance Technological innovation of pharmaceutical manufacturing
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024092296